List of Excipients in Branded Drug ANTI-DIARRHEAL

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	BUTYLATED HYDROXYANISOLE
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	FD&C BLUE NO. 1
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	GELATIN
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	GLYCERIN
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	GLYCERYL CAPRYLATE
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	POLYOXYL 40 HYDROGENATED CASTOR OIL
WALGREENS	ANTI-DIARRHEAL	loperamide hydrochloride	0363-1176	WATER

Generic Drugs Containing ANTI-DIARRHEAL

Company	Ingredient	NDC	Excipient
Walgreen Company	loperamide hcl	0363-0375	CELLULOSE, MICROCRYSTALLINE
Walgreen Company	loperamide hcl	0363-0375	D&C YELLOW NO. 10 ALUMINUM LAKE
Walgreen Company	loperamide hcl	0363-0375	DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Walgreen Company	loperamide hcl	0363-0375	FD&C BLUE NO. 1 ALUMINUM LAKE
Walgreen Company	loperamide hcl	0363-0375	MAGNESIUM STEARATE
Walgreen Company	loperamide hcl	0363-0375	SILICON DIOXIDE
Walgreen Company	loperamide hcl	0363-0375	STARCH, CORN

What are the Most Frequently-Used Excipients in ANTI-DIARRHEAL?

# Of NDCs	Excipient
1	ANHYDROUS CITRIC ACID
1	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
1	ANHYDROUS LACTOSE
1	CARBOXYMETHYLCELLULOSE SODIUM
30	CELLULOSE, MICROCRYSTALLINE
1	CROSCARMELLOSE SODIUM
1	CROSPOVIDONE

Excipient Strategy and Commercial Opportunities for Anti-Diarrheal Drugs

Last updated: February 26, 2026

What is the role of excipients in anti-diarrheal medications?

Excipients stabilize formulations, enhance bioavailability, improve patient compliance, and extend shelf life. For anti-diarrheal drugs, excipients serve as fillers, binders, disintegrants, stabilizers, and preservatives. They ensure manufacturing efficiency and predictable drug performance.

How do excipient choices influence formulation effectiveness?

Excipient selection impacts drug release profiles, stability, and tolerability. Anti-diarrheal drugs—such as loperamide, bismuth subsalicylate, or crofelemer—require excipients that do not compromise their efficacy or cause adverse effects like gastrointestinal irritation.

Common excipients in anti-diarrheal formulations

• Binders: Microcrystalline cellulose provides mechanical strength.
• Disintegrants: Croscarmellose sodium promotes rapid tablet disintegration.
• Fillers: Lactose enhances tablet volume and flexibility.
• Preservatives: Benzalkonium chloride prevents microbial growth.
• Sweeteners: Aspartame improves palatability.

What are the key manufacturing considerations?

Formulators prioritize excipients that are non-interacting with active ingredients, cost-effective, and compliant with regulatory standards. Compatibility testing verifies that excipients do not influence drug stability or efficacy over shelf life.

What are the commercial opportunities in excipient innovation for anti-diarrheal drugs?

Market potential

The global anti-diarrheal market, valued at approximately USD 1.4 billion in 2022, is expected to grow at a compound annual growth rate (CAGR) of about 4.5% through 2030. Drivers include emerging markets, increasing prevalence of gastrointestinal conditions, and demand for improved formulations.

Opportunities for new excipient development

1. Enhanced bioavailability: Novel excipients that improve drug absorption can increase therapeutic effectiveness, positioning products for premium pricing.
2. Improved stability: Encapsulation or stabilization agents extend shelf life, reducing waste and supply chain costs.
3. Patient compliance: Palatable, easy-to-dissolve formulations using advanced sweeteners or disintegrants expand market reach, especially in pediatric or geriatric populations.
4. Regulatory advantages: Excipient innovations that meet or exceed current safety standards can streamline approval and differentiate products.

Strategic considerations

• Development of multifunctional excipients that combine disintegration, disinfection, and stabilization.
• Collaboration with excipient manufacturers to customize formulations.
• Investment in sustainable, plant-based excipients appealing to eco-conscious markets.

How do regulatory trends influence excipient use?

Regulators seek transparency and safety. The U.S. FDA and EMA maintain lists of approved excipients, with increased scrutiny on novel or proprietary excipients, especially those derived from non-traditional sources. Clear documentation and safety data are essential for market approval.

What are the key challenges?

• Ensuring excipient compatibility with active ingredients.
• Avoiding excipient-induced side effects.
• Navigating complex regulatory pathways for novel excipients.
• Managing supply chain disruptions, especially for specialty or high-purity excipients.

Conclusion

Formulation success in anti-diarrheal drugs depends on strategic excipient selection. Innovation in excipients offers pathways to enhanced drug efficacy, stability, patient compliance, and regulatory advantage. Market growth and regulatory pressures emphasize the importance of tailored, safe, and sustainable excipient choices.

Key Takeaways

• Excipients are critical for the stability, bioavailability, and patient acceptance of anti-diarrheal drugs.
• Custom excipients that enhance absorption and stability present significant commercial opportunities.
• Regulatory landscapes favor transparency and safety data, influencing excipient selection.
• The expanding anti-diarrheal market underscores increased demand for advanced formulation strategies.
• Collaboration with excipient suppliers and focus on sustainability can provide competitive advantage.

FAQs

1. What are the most common excipients in anti-diarrheal capsules?
Microcrystalline cellulose (binder), croscarmellose sodium (disintegrant), lactose (filler), and glycerin (plasticizer) are typical.

2. Can novel excipients replace traditional ones in anti-diarrheal formulations?
Yes, if they demonstrate improved stability, bioavailability, or patient tolerability, and meet regulatory approval standards.

3. How do excipients affect the shelf life of anti-diarrheal products?
They influence stability by protecting active ingredients from degradation, controlling moisture, and preventing microbial growth.

4. What regulatory considerations apply to excipients in anti-diarrheal drugs?
Excipients must be approved for use, non-toxic, and compatible with active ingredients. Documentation and safety assessments are necessary for regulatory clearance.

5. Are there sustainable excipient options suitable for anti-diarrheal formulations?
Yes, plant-based or biodegradable excipients are gaining interest due to regulatory and consumer preferences for sustainability.

---

References

[1] U.S. Food and Drug Administration. (2022). Inactive Ingredient Database. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCLIA/
[2] MarketLine. (2023). Global Anti-Diarrheal Drugs Market Report.
[3] European Medicines Agency. (2022). Guideline on Excipients in the Dossiers for Marketing Authorization of Medicines.